Türkkan Evrensel

18PUBLICATIONS
126CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 15, 2026
Promoter Methylation and Somatic Mutations in Cancer-Related Genes Are Associated with Hyperprogressive Disease in Patients with Malignant Melanoma and Renal Cell Carcinoma Receiving Anti-PD-1/PD-L1 Immunotherapy.

|Jun 11, 2026
Association Between Blood Transfusion and Survival Outcomes in Metastatic Cutaneous Melanoma Treated with Nivolumab.

|Mar 28, 2026
Integrating Tumor Biology and Host Factors in mCRPC: The Prognostic Value of 'Time to Castration Resistance', Systemic Inflammation, and Comorbidity Burden in Patients Treated with Enzalutamide.

Seda Sali, Arife Ulaş, Sibel Oyucu Orhan

|Feb 27, 2026
Association of IMP3 and CD10 Expression with Clinicopathological Features and Outcomes in Phyllodes Tumors: A Retrospective Single-Center Study.

Hülya Odabaşı Bükün, Erdem Çubukçu, Adem Deligönül

|Feb 27, 2026
Predicting the Unpredictable: Prognostic Role of Systemic Inflammatory Indices and Tumor Biology of Neoadjuvant Chemotherapy Response in Gastric and Gastroesophageal Junction Cancer-Insights from a Systematic Review and Real-World Experience.

Sibel Oyucu Orhan, Bedrettin Orhan, Yağmur Çakır

|Dec 31, 2025
Prognostic Value of Histological Subtypes and Clinical Factors in Non-Endemic Nasopharyngeal Carcinoma: A Retrospective Cohort Study.

Seda Sali, Candan Demiröz Abakay, Mürsel Sali

Pageof 3

Frequent Collaborators

8 joint publications

Ahmet Bilgehan Şahin

6 joint publications

Seda Sali

6 joint publications

Erdem Çubukçu

5 joint publications

Adem Deligönül